• Marc J Schweiger, Charles E Chambers, Charles J Davidson, Shaoheng Zhang, James Blankenship, Narinder P Bhalla, Peter C Block, John P Dervan, Christine Gasperetti, Lowell Gerber, Neal S Kleiman, Ronald J Krone, William J Phillips, Robert M Siegel, Barry F Uretsky, and Warren K Laskey.
• Division of Cardiology, Baystate Medical Center, Springfield, MA 01199, USA. marc.schweiger@bhs.org
• Catheter Cardiovasc Interv. 2007 Jan 1; 69 (1): 135-40.

AbstractContrast induced nephropathy (CIN) is the third leading cause of hospital acquired renal failure and is associated with significant morbidity and mortality. Chronic kidney disease is the primary predisposing factor for CIN. As estimated glomerular filtration rate<60 ml/1.73 m2 represents significant renal dysfunction and defines patients at high risk. Modifiable risk factors for CIN include hydration status, the type and amount of contrast, use of concomitant nephrotoxic agents and recent contrast administration. The cornerstone of CIN prevention, in both the high and low risk patients, is adequate parenteral volume repletion. In the patient at increased risk for CIN it is often appropriate to withhold potentially nephrotoxic medications, and consider the use of n-acetylcysteine. In patients at increased risk for CIN the use of low or iso-osomolar contrast agents should be utilized and strategies employed to minimize contrast volume. In these patients serum creatinine should be obtained forty-eight hours post procedure and it is often appropriate to continue withholding medications such as metformin or non steroidal anti-inflammatories until renal function returns to normal.Copyright (c) 2006 Wiley-Liss, Inc.

14 keywords...

hide…